Catalyst
Slingshot members are tracking this event:
Viiv Healthcare Presents Results from 2 Phase 3 Studies Evaluating Dolutegravir + Rilpivirine in HIV Maintenance
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PFE |
|
|
JNJ |
|
|
GSK |
|
|
SGIOF |
|
|
Viiv Healthcare |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 20, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Dolutegravir, Rilpivirine
